Home › Funds › PALISADE CAPITAL MANAGEMENT, LP › ABBV

PALISADE CAPITAL MANAGEMENT, LP position in ABBV

ABBVIE INC · Health Care

PALISADE CAPITAL MANAGEMENT, LP reported holding 70,447 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$18.4M, representing 1.41% of its reported portfolio and ranking #17 among its reported holdings. PALISADE CAPITAL MANAGEMENT, LP has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)70.45K sh
Reported value held$18.43M
Portfolio Weight1.41%
First reportedQ3 2023
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How PALISADE CAPITAL MANAGEMENT, LP's ABBV position evolved

PALISADE CAPITAL MANAGEMENT, LP first disclosed a stake in ABBV in Q3 2023 at 85,791 shares (US$12.8M). The position peaked in Q3 2026 at 70,447 shares, worth US$18.4M. Across 13 filings, PALISADE CAPITAL MANAGEMENT, LP increased the stake 4 time(s), trimmed it 3 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 70,447 shares valued at US$18.4M — a reduction of -458 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 85.79K $12.79M New
Q4 2023 85.59K $13.26M Hold
Q1 2024 68.17K $12.41M Reduce
Q2 2024 68.97K $11.83M Add
Q3 2024 69.00K $13.63M Hold
Q4 2024 69.17K $12.29M Hold
Q1 2025 68.08K $14.26M Reduce
Q2 2025 67.75K $12.58M Hold
Q3 2025 68.37K $15.83M Add
Q4 2025 70.49K $16.11M Add
Q1 2026 71.17K $15.48M Add
Q2 2026 70.91K $17.84M Hold
Q3 2026 70.45K $18.43M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 32 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$38.97B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has PALISADE CAPITAL MANAGEMENT, LP held ABBV?

PALISADE CAPITAL MANAGEMENT, LP has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is PALISADE CAPITAL MANAGEMENT, LP's current position in ABBV?

As of Q3 2026, PALISADE CAPITAL MANAGEMENT, LP holds 70.45K shares of ABBV (ABBVIE INC), valued at $18.43M, representing 1.41% of its reported portfolio and ranking #17.

Has PALISADE CAPITAL MANAGEMENT, LP been buying or selling ABBV?

In the latest 13F filing (Q3 2026), PALISADE CAPITAL MANAGEMENT, LP reduced its position in ABBV. The position peaked in Q3 2026 at 70.45K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.